Tag:
BGC 945
Latest Headlines
Latest Headlines
Onyx, BTG ink $320M licensing deal
In another pipeline-building move, California's Onyx Pharmaceuticals has shelled out $320 million for BTG's preclinical anticancer compound, BGC 945. BTG gets $13 million up front and could receive
